Published in Drug Law Weekly, May 3rd, 2005
The planned interim safety analysis was conducted after the first 54 patients were treated in the trial. The DMC is comprised of independent physicians and a statistician and was established to monitor the safety data from the trial. Based upon their review of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.